Learning from patient and site perspectives to develop better digital health trials: Recommendations from the Clinical Trials Transformation Initiative.

MedStar author(s):
Citation: Contemporary Clinical Trials Communications. 19:100636, 2020 Sep.PMID: 32913915Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2020ISSN:
  • 2451-8654
Name of journal: Contemporary clinical trials communicationsAbstract: In order to harness the potential of digital health technologies to enhance the quality of clinical research, it is critical to first understand how to engage patients and research sites when planning and conducting digital health trials. To pave the way for the more effective use of digital health technologies in trials, the Clinical Trials Transformation Initiative has developed the first comprehensive, evidence-based set of recommendations for incorporating patient and site perspectives in digital health trials. While directed primarily at sponsors, these recommendations are expected to be valuable for all stakeholders including investigators. Copyright (c) 2020 Published by Elsevier Inc.All authors: Bemden AB, Geoghegan C, Hallinan Z, Jordan L, Kehoe LS, Morin SL, Nido V, Niskar A, Okubagzi PG, Wood WAFiscal year: FY2021Digital Object Identifier: Date added to catalog: 2020-10-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32913915 Available 32913915

In order to harness the potential of digital health technologies to enhance the quality of clinical research, it is critical to first understand how to engage patients and research sites when planning and conducting digital health trials. To pave the way for the more effective use of digital health technologies in trials, the Clinical Trials Transformation Initiative has developed the first comprehensive, evidence-based set of recommendations for incorporating patient and site perspectives in digital health trials. While directed primarily at sponsors, these recommendations are expected to be valuable for all stakeholders including investigators. Copyright (c) 2020 Published by Elsevier Inc.

English

Powered by Koha